Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.

BACKGROUND: Primary intestinal lymphangiectasia (PIL), first described in 1961, is a rare disorder of unknown etiology resulting in protein-losing enteropathy. The disease is characterized by dilatation and leakage of intestinal lymph vessels leading to hypoalbuminemia, hypogammaglobulinemia, and lymphopenia. Since the severity and location of lymph vessels being affected can vary considerably, the range of associated symptoms is wide from mild lower-limb edema to generalized edema, abdominal and/or pleural effusion, and recurrent diarrhea, among others. Although usually developing in early childhood, we present the case of a 34-year-old woman with PIL. Moreover, we performed a literature review systematically assessing clinical presentation, and provide a practical approach to facilitate diagnosis and therapy of PIL in adults. CASE
SUMMARY: Our patient presented with unspecific symptoms of abdominal discomfort, fatigue, nausea, and recurrent edema of the lower limbs. Interestingly, a striking collinearity of clinical symptoms with female hormone status was evident. Additionally, polyglobulia, hypoalbuminemia, hypogammaglobulinemia, and transient lymphocytopenia were evident. Due to suspicion of a bone marrow disease, an extensive diagnostic investigation was carried out excluding secondary causes of polyglobulinemia and hypoalbuminemia. The diagnosis of primary intestinal lymphangiectasia was established after 22 wk by histological analysis of biopsy samples obtained via enteroscopy. Consecutively, the patient was put on a high-protein and low-fat diet with medium-chain triglycerides supplementation leading to significant improvement of clinical symptoms until 2 years of follow-up.
CONCLUSION: PIL can be the reason for cryptogenic hypoalbuminemia, hypogammaglobulinemia, and lymphopenia in adulthood. Due to difficulty in correct diagnosis, treatment initiation is often delayed despite being effective and well-tolerated. This leads to a significant disease burden in affected patients. PIL is increasingly been recognized in adults since the majority of case reports were published within the last 10 years, pointing towards an underestimation of the true prevalence. The association with female hormone status warrants further investigation. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Core Tip: Although Primary intestinal lymphangiectasia usually develops in early childhood, we present the case of a 34-year-old woman. We observed a striking collinearity with female hormone status in our patient, presenting a potential area of future research. Moreover, we performed a literature review of all published case reports so far and systematically assessed clinical presentation to provide a practical approach to facilitate diagnosis and therapy of primary intestinal lymphangiectasia in adults for the first time.

INTRODUCTION

Primary intestinal lymphangiectasia (PIL) has been first described by Waldmann et al[1] in 1961 as a rare disorder of intestinal lymphangiectasia that results in protein-losing enteropathy (PLE)[1]. PIL is caused by a diffuse or localized dilatation and/or rupture of intestinal lymphatic vessels in the mucosa, submucosa, or subserosa due to high pressure in lymphatic vessels[2]. Importantly, prevalence and etiology are yet unknown. However, genetic associations are been discussed since the diagnosis is generally established in childhood with very rare cases in adults[3].

Symptoms largely relate to the severity of lymph loss and consecutive loss of proteins resulting in hypoproteinemia, lymphopenia, and decreased serum levels of immunoglobulins. Among others, these symptoms include pitting edemas of the lower limbs, generalized edema, as well as pleural, epicardial, or often chylous abdominal effusion[4]. Here, we present the case of PIL in a 34-year-old female patient, together with a literature review of all case reports on PIL in adulthood (using the terms “Primary intestinal lymphangiectasia” and “Waldman’s disease”), focusing on clinical presentation, and providing a diagnostic and therapeutic overview for clinicians to enhance recognition and facilitate diagnosis.

CASE PRESENTATION

Chief complaints

In October 2018, a 34-year-old woman presented with recurring nausea independent of food intake, episodes of abdominal discomfort, fatigue, occasional episodes of diarrhea as well as a feeling of increased susceptibility to opportunistic infections.

History of present illness

After the end of pregnancy earlier this year, she reported on more frequently observed limb edema. The other medical history including comorbidities and drug intake were unremarkable.

History of past illness

Interestingly, temporary facial edema were occasionally reported already during childhood starting at the age of 12. After puberty, pronounced edema of the lower limbs, recurring nausea and fatigue were continuously reported, but vanished when using oral contraceptives or during pregnancy.

Physical examination

The physical examination at the initial contact did not reveal any abnormalities. Especially, no edema of the upper or lower limb were observed and weight was stable with a body mass index of 18.3 kg/m².

Laboratory examinations

During several routine blood tests after pregnancy, polyglobulia [hemoglobin 17.4 g/dL (normal range: 12.3-15.3 g/dL), blood count 5.82 (normal range: 3.60-5.00)], normal leukocyte count (4.48, normal range: 4.40-11.30) with diminished lymphocyte count (14.6%, normal range: 19.3%-51.7%) following differential blood count, and reduced total serum protein (4.9 g/dL, normal range: 6.2-8.2 g/dL) with hypoalbuminemia (2.8 g/dL, normal range: 3.4-5.0 g/dL) were observed. Additionally, quantitative immunoglobulin analysis displayed hypogammaglobulinemia of 7.3% (normal range: 11.1%-18.8%) with a pronounced deficiency of the IgG class (268 mg/dL, normal range: 700-1600 mg/dL), moderate deficiency of IgA class (54 mg/dL (normal range: 70-500 mg/dL), and reduced IgG-1 and IgG-2 subclasses (193 mg/dL, normal range: 405-1011 mg/dL; 93 mg/dL, normal range: 169-786 mg/dL). Additionally, the CD4: CD8 T-cell ratio was reduced [0.9 (normal range: 1.0–3.6) and kappa and lambda light-chains were diminished [75 mg/dL (normal range: 173-383 mg/dL), 46 mg/dL (normal range: 81-192 mg/dL)]. The urinary sediment showed no proteinuria and no signs of renal, hepatic, pancreatic, or cardiac disease. Since the laboratory constellation pointed towards a cellular and humoral immune defect, exhaustive investigations were started. Negative results for JAK2 mutations (JAK2-exon 12 sequencing and JAK2-mutation V617F) and negative BCR/ABL ratio ruled out polycythemia vera. Additionally, bone marrow analysis neither showed myeloid neoplasia nor infiltration by lymphoma, and ß2-microglobulin was within the normal range ruling out a hematogenous disease. Autoantibody screening and virus serology including hepatitis viridae, cytomegalovirus, Epstein-Bar virus, and human immunodeficiency virus were negative, and pancreatic insufficiency was excluded.

Imaging examinations

Incidentally, abdominopelvic computerized tomography (CT) showed a thickened wall of the ileum and jejunum with enlarged mesenteric lymph nodes up to 32 mm localized in the lower abdomen. Therefore, an ileocolonoscopy with exploration of > 8 cm of the ileum was performed showing a normal result. After CT-findings were confirmed on magnetic resonance imaging, a gastroduodenoscopy with standard intubation to the mid-descending duodenum revealed creamy white spots of the duodenal mucosa, suggesting lymphedema (Figure 1A). However, the histological evaluation did not show evidence for dilated lymph vessels or PIL, giardiasis, celiac disease, Whipple disease, or intestinal bowel disease, which was additionally excluded by normal calprotectin levels. Following video capsule endoscopy that showed a snowflake appearance of the mucosa (Figure 1B), double-balloon enteroscopy exploring approximately 70 cm of the jejunum verified mucosal lesions compatible with lymphangiectasia macroscopically (Figure 1C).

Figure 1

Imaging examinations. A: Endoscopic view of the descending part of the duodenum showing spots of lymphangiectasia suggestive for lymphedema; B: Video capsule endoscopy with a snowflake appearance of the jejunum compatible with dilated mucosal lymphatic vessels; and C: Double-balloon enteroscopy of the jejunum with an almost identical image to video capsule endoscopy.

FINAL DIAGNOSIS

Finally, PIL was confirmed on histological and immunohistological analyses from jejunal biopsies (Figures 2 and 3).

Figure 2

Histological and immunohistological analyses. A: Jejunal biopsies showing a mild and focal blunting of the villi in particular above the prominent ecstatic mucosal lymph vessels (4-fold magnification); B: Ecstatic lymph vessel without inflammatory changes or abnormalities of the epithelial intestinal cell lining (200-fold magnification).

Figure 3

Histological and immunohistological analyses. A: Periodic Acid-Schiff staining did not reveal any collections of periodic acid-schiff positive histiocytes or inclusions, demonstrating the perfectly normal intestinal brush border (200-fold magnification); B: Immunohistochemistry for D2-40, a marker of lymphatic endothelial cells, confirms the endothelium to be of lymphatic origin and highlights the presence of multiple ecstatic lymph vessels in both the mucosa and submucosa (100-fold magnification). 

TREATMENT

After putting the patient on a medium-chain triglyceride (MCT) diet rich in protein, the clinical condition of the patient significantly improved within 4 wk.

OUTCOME AND FOLLOW-UP

Until 2 years after diagnosis, mild lower limb edema were only observed between the end of breastfeeding period and a second pregnancy, and abdominal discomfort, fatigue and nausea significantly improved. Laboratory improvement was characterized by increase in total serum protein, albumin, and quantitative immunoglobulin levels.

DISCUSSION

Due to the rarity of this disease, the worldwide incidence of PIL in humans is unknown[3]. However, a genetic predisposition is been discussed since if mostly affects children below 3 years of age[5]. This is supported by familial forms of specific syndromes that have been associated with PIL, including the yellow-nail syndrome, von Recklinghausen’s disease, Turner, Noonan, Klippel-Trenaunay or Hennekam syndrome[3,6,7]. Nevertheless, cases in adult patients exist. We performed a literature review and could identify 49 cases from 46 case reports of PIL in adults in which the onset of symptoms occurred after the 18th birthday (Table 1, Supplementary Table 1[8-53]). Notably, 27/46 (58.7%) were published since 2010, indicating that this entity is increasingly been recognized and the prevalence might be underestimated. Median age at diagnosis was 43 (range: 20-83) years while median time from onset of symptoms to final diagnosis was 3 (range: 0-40) years, highlighting the difficulty in the correct diagnosis of this entity. Although a literature review of PIL cases existed reporting a mean age of 13.3 years at symptom onset and 8.5 years until diagnosis, it has to be pointed out that 75% of cases in this review included patients with symptom onset before 20 years of age[54]. In terms of gender distribution, 22 male (44.9%) and 27 female (55.1%) cases were reported.

Table 1

Clinical presentation, laboratory findings and endoscopic diagnosis of all case reports describing adult patients1 with primary intestinal lymphangiectasia

Clinical presentation		n
Patient characteristics	Number of adult patients with PIL	49
	Age at diagnosis, yr	43 (20-83)
	Time to final diagnosis, yr	3 (0-40)
	Male, n (%)	21 (42.9)
	Female, n (%)	28 (57.1)
Symptoms, n (%)	Edema	40/48 (83.3)
	Recurrent diarrhea	20/48 (41.7)
	Abdominal effusion	13/48 (27.1)
	Pleural effusion	10/48 (20.8)
	Abdominal pain	9/48 (18.8)
Laboratory findings, n (%)	Hypogammaglobulinemia	35/48 (72.9)
	Hypoalbuminemia	35/48 (72.9)
	Lymphocytopenia	30/48 (62.5)
	Hypoproteinemia	26/48 (54.2)
	Hypocalcemia	12/48 (25.0)
	α1-antitrypsin (stool)	10/48 (20.8)2
CT-scan, n (%)	Normal	8/27 (29.6)
	Thickened wall of small bowel	11/27 (40.7)
Diagnosis possible, n (%)	Gastro-duodenoscopy	21/35 (60.0)
	Ileo-colonoscopy	5/21 (23.8)
	Enteroscopy	13/13 (100)

Diagnosis established after the 18th birthday.

All patients (100%) in which α1-antitrypsin levels or α1-antitrypsin clearance was measured in stool samples reported elevated results. CT: Computerized tomography.

Our case describes a 34-year-old female being diagnosed with PIL around 22 years after the first occurrence of edema, and 22 wk after the first contact at our institution. She presented with nausea, abdominal discomfort, diarrhea, and bilateral limb edemas. From 48 patients reporting on symptoms in the literature, 40 patients (83.3%) reported the presence of any peripheral/generalized edema while only 2 patients did not present with edema and 6 case reports did not report on this symptom. The majority (n = 27, 56.3%) only reported bilateral edema of the lower limb. 9/48 patients (18.8%) presented with abdominal pain, 13 patients (27.1%) presented with (chylous) ascites, 10 patients (20.8%) with pleural, and 4 patients (8.3%) with pericardial effusion. Diarrhea was present in 20/48 patients (41.7%). Other rare unspecific symptoms include changes in weight, nausea, general weakness, pallor, and gastrointestinal bleeding. These findings go in line with a former literature review of 84 PIL cases (including predominantly children), reporting limb edema, diarrhea, ascites, and lymphedema in 78%, 62%, 41%, and 22% respectively[54]. These symptoms and their varying extent can largely be explained as a consequence of lymphatic/ protein and subsequently watery loss due to lower oncotic pressure in interstitial fluid.

The fact that pregnancy and oral contraception led to the vanishing of edemas in our patient is indeed surprising as this has not yet been reported. Of note, symptoms completely resolved when taking oral contraceptives and re-appeared during pill-free days in between. One may hypothesize that differences in estradiol might influence the severity of lymphedema: Morfoisse et al[55], who explored the role of estrogens on lymphatic endothelial cells, found that estradiol is protective of lymphedema, and blockage of the estrogen receptor is associated with stronger lymphatic leakage. However, this was only shown in an animal model of secondary lymphedema, and no other studies providing further evidence on this mechanism are available.

Among the most frequently observed laboratory findings in literature were anemia in 16 patients (33.3%), lymphocytopenia in 30 (62.5%), hypoproteinemia in 26 (54.2%), and hypoalbuminemia and hypogammaglobulinemia/reduced serum IgG level in 35 (72.9%) while no patients specifically reported the absence of the latter two laboratory findings. However, these numbers might be underestimated since not all case reports reported on these features. 12 patients (25.0%) specifically reported reduced serum levels of calcium and 5 patients (10.4%) reduced levels of magnesium, leading to occasional muscle seizures in several patients. Other findings include hypoglobulinemia with reduced numbers of IgM, IgA, and IgG, and reduced numbers of CD3+ and CD4+ cells. Profound hypoproteinemia, hypoalbuminemia, and hypogammaglobulinemia and reduced CD4:CD8 ratio could also be confirmed in our patient. However, lymphocytopenia was only transient and leucocyte count was within the normal range indicating that these parameters might be very unspecific and significantly influenced by temporary inflammatory processes in the body. This is especially true since an increased susceptibility to opportunistic infections based on lymphocytopenia and hypogammaglobulinemia could be present. This was reported in our patient, 2 case reports of adult patients with additional 2 patients suffering from cryptococcal meningitis at initial presentation, and 3 case reports of children[5]. This humoral and cellular immunodeficiency is assumed to be due to a lymphatic loss of B- and T- lymphocytes. Interestingly, 4 patients in the literature report an extensive presence of warts, probably representing the end-stage of acquired immunodeficiency.

Notably, fecal α1-antitrypsin levels or α1-antitrypsin-clearance seem to be a good indicator for the presence of PLE/PIL in these patients with positive results in all patients who reported on this feature (10/48, 20.8%). Since α1-antitrypsin is resistant to degradation by digestive enzymes, it indicates the presence of blood proteins in the intestinal tract[56].

Because of persistently diminished IgG and IgA, an abdominal/pelvic CT scan was performed to rule out lymphoma or thymoma in our patient. This incidentally revealed a thickened wall in the jejunum and ileum with enlarged lymph nodes. Interestingly – when looking into the literature – 11/27 of patients (40.7%) undergoing a CT scan reported abnormalities in the small bowel wall while 8/27 (29.6%) had a completely normal result. However, other imaging modalities such as lymphangioscintigraphy or technetium-labeled human serum albumin (99TmTc-HSA) scintigraphy might be of higher accuracy pointing towards the diagnosis of PIL, demonstrating abnormal lymphatic, or protein leakage.

When comparing endoscopic findings in these patients, 21/35 (60.0%) gastroduodenoscopies performed in symptomatic PIL patients revealed an endoscopic view suggestive for PIL with “snowflake appearance” of the duodenal mucosa indicating lymphatic dilations while in 2 patients the diagnosis could be made histologically despite normal macroscopic appearance. On the contrary, ileocolonoscopy was inferior with only 5/21 (23.8%) showing characteristic features in the terminal ileum that led to the diagnosis. However, it has to be mentioned that considering the improvement in technology, this rate might be underestimated due to the large number of studies performed > 10 years ago. Enteroscopy, which was performed in 14 patients including our patient to establish the diagnosis, is highly sensitive and should be regarded as the gold-standard for diagnosis. Video capsule endoscopy could be used to help with diagnosis, being similarly sensitive to detect lymphedema in the small bowel.

In our case, although a gastroduodenoscopy was performed showing an endoscopic snowflake appearance of the duodenal mucosa indicating lymphatic dilations, the histological report was normal. To our opinion, two possible explanations exist for this phenomenon: On the one hand, the dilated lymphatic endothelial cells can be distributed in different locations in the intestine to a different extent, hence the histology specimens might not show dilated lymphatic endothelial cells despite endoscopic and macroscopic appearance. On the other hand, the lack of experience of pathologists with this entity could result in an insufficient evaluation of the histological specimens and delay of diagnosis, as this was the case in our patient.

Lifelong adherence to a diet rich in protein with substitution of MCT remains the cornerstone in the therapy of PIL. Because MCTs are directly absorbed into the portal venous system bypassing the lymphatic system, they can be used to overcome chronic malnutrition. The need for dietary control in people appears to be permanent because clinical and biochemical findings seem to reappear after low-fat dietary withdrawal. 16/26 patients (61.5%) receiving MCT alone reported significant improvement in symptoms while 2 patients reported only moderate improvement. Octreotide can be regarded as the preferred treatment in patients in whom dietary changes fail to achieve significant improvement. Octreotide is a long-acting somatostatin analogue that suppresses gastrointestinal motility and hormone secretion in the pituitary gland, pancreas, and intestine. Although the mechanism of action of octreotide in diminishing protein loss through the gastrointestinal tract is unclear, theorized mechanisms of octreotide’s action in PIL include decreased intestinal fat absorption, inhibition of gastrointestinal vasoactive peptides, and stimulation of the autonomic nervous system[57-59]. Octreotide is usually given at doses of 150-200 µg subcutaneously twice daily[14]. From all 29 cases that reported efficacy of therapy, octreotide was added to MCT in 6 patients and started as initial treatment in one patient, with 2 patients having an insufficient response and 2 patients report in recurrence of symptoms after discontinuation of octreotide with otherwise good response. Other medical therapeutic options include propranolol, which is thought to downregulate the RAF mitogen-activated protein kinase signaling pathway with reduced expression of VEGF, and everolimus, which is an mTOR inhibitor. mTOR is a serine/threonine kinase, representing a key enzyme for numerous cellular processes including angiogenesis and cell growth. Ozeki et al[60] found significant mTOR expression in tissues affected by PIL and applied everolimus (1.6 mg/m²/day) as a treatment of PIL improving diarrhea and hypoproteinemia. However, no case report on an adult patient with PIL exists using these two substances. Surgical resection seems to be the last option both for diagnosis and therapy of PIL. In 6/49 patients, diagnosis of PIL was established after surgical resection, however in most cases without performing an enteroscopy before. All 7 patients that reported surgical resection as the form of treatment – sometimes after the failure of conservative therapy – described improvement of the clinical condition after surgery. However, long-term follow-up does not exist in these patients.

Nevertheless, long-term follow-up is needed since lymphoma have been described as long-term complications in patients with PIL. Laharie et al[40] reported on 12 cases of lymphoma after PIL, which was adopted for the present case report and completed by literature review of additional cases until 2020[61]. So far, 13 cases have been published with lymphoma occurring after a median of 14 years (range: 0-39) after PIL diagnosis (Supplementary Table 2).

CONCLUSION

In conclusion, PIL can be a rare cause of PLE in adults. Unspecific symptoms and a wide range of clinical manifestations can significantly hamper establishing the definite diagnosis, leading to a “diagnostic roller coaster” for the individual patient. Despite good treatment options, low recognition of this entity leads to significant morbidity in these patients. Following review of published case reports, we present a practical overview of symptoms, laboratory findings, the accuracy of diagnostic modalities, and a potential treatment approach to facilitate diagnosis, and management of these patients. Finally, we highlight the striking collinearity with female hormone status in our patient, presenting a potential area of future research (Figure 4).

Figure 4

Proposed algorithm for diagnosis and therapy of primary intestinal lymphangiectasia in adults.  1Including intubation of the terminal ileum. 2Other secondary causes include: Retroperitoneal fibrosis following radio-/chemotherapy, sarcoidosis, intestinal tuberculosis, systemic sclerosis, human immunodeficiency virus-related enteropathy, Fontan-surgery.